通过歧视性分析识别使用异质性来识别两种不同的神经解剖学亚型的第一次情节抑郁症
Yuan Chen1, Yi Chen2, Ruiping Zheng1
1Department of Magnetic Resonance Imaging, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China; Engineering Technology Research Center for Detection and Application of Brain Function of Henan Province, Zhengzhou, Henan 450000, China; Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment of Henan Province, Zhengzhou, Henan 450000, China; Engineering Research Center of Brain Function Development and Application of Henan Province, Zhengzhou, Henan 450000, China; Key Laboratory of Brain Function and Cognitive Magnetic Resonance Imaging of Zhengzhou, Zhengzhou, Henan 450000, China; Key Laboratory of Imaging Intelligence Research Medicine of Henan Province, Zhengzhou, Henan 450000, China.
这项研究在使用机器学习对灰色物质体积的研究中确定了两种不同的神经解剖学亚型,用于首发抑郁症. 这些亚型显示相反的结构性大脑变化,为抑郁症异质性和潜在诊断提供了新的见解.
科学领域:
- 神经成像是一种神经成像.
- 机器学习 机器学习
- 精神病学是一个精神病学.
背景情况:
- 抑郁症中的神经生物学异质性导致神经成像结果不一致.
- 了解这些差异对于准确的诊断和治疗至关重要.
研究的目的:
- 通过使用一种新的机器学习方法,研究第一期治疗前的抑郁症的神经解剖学亚型.
- 根据灰色物质体积 (GMVs) 探索不同的亚型.
主要方法:
- 从195名患者和78名健康对照的T1加权MRI扫描中利用了灰质体积 (GMV).
- 通过歧视性分析 (HYDRA) 采用异质性来识别基于区域转基因病毒的亚型.
主要成果:
- 与健康对照人群相比,确定了两种不同的抑郁症亚型,具有相反的结构变化.
- 第1亚型显示GMVs增加 (额头,额头,皮层,边缘系统);第2亚型显示GMVs减少 (丘脑,小脑,边缘系统).
- 亚型2的总内体积 (TIV) 较小,疾病持续时间较长;TIV与亚型1的发病年龄相关,但与亚型2无关.
结论:
- 揭示了两种不同的神经解剖学亚型的第一期抑郁症.
- 提供了对抑郁症异质性背后的生物学机制的新见解.
- 可能有助于准确的临床诊断和未来的治疗策略.
更多相关视频
05:19Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
08:33Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
Published on: December 4, 2014
相关概念视频
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
Depressive Disorders: MDD and Dysthymia
Antidepressant Drugs: MAOIs and Other Agents
